DAVEXLABS LLC has been acquired by WestView Capital Partners
DAVEXLABS LLC, doing business as L’ANZA, has been sold to WestView Capital Partners. Financial details have not been disclosed.
DAVEXLABS LLC, doing business as L’ANZA, develops and markets salon hair care products for individual hair needs. The company offers healing oils, such as shampoos, conditioners, hair sprays, and styling products, as well as service-based products, including hair color and treatment systems. It also provides professional salon services. The company sells its products through professional salons in the US and internationally. DAVEXLABS LLC was founded in 2002 and is based in Santa Monica, California.
WestView Capital Partners is a private equity firm specializing in equity investments in minority and majority recapitalization, growth capital financings, acquisitions, leveraged buyouts, industry consolidations, and lower middle-market companies. It also invests in add-on acquisitions. The firm invests in business services, industrial and manufacturing, software and information technology services, consumer, healthcare technology and outsourcing, growth industrial, technology enabled companies, distribution and logistics, consumer products and retail, healthcare services, environmental services, and media and publishing. It prefers to invest in companies based in North America. WestView Capital Partners was founded in 2004 and is based in Boston, Massachusetts.
Oaklins' team in Los Angeles advised the seller in this transaction.
Talk to the deal team
Adam Abramowitz
Oaklins Intrepid
Steven Davis
Oaklins Intrepid
Gary S. Rabishaw
Oaklins Intrepid
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more